摘要 |
The invention provides for a cell permeable peptide conjugated to an insulin compound for improved cell penetration of the insulin moiety. The composition may be delivered by intravenous, intramuscular, subcutaneous, intranasal, oral inhalation, intrarectal, intravaginal or intraperitoneal means for the treatment, including prophylaxis of Type I, Type II diabetes, prediabetes and/or metabolic syndrome.
|
申请人 |
SMITHKLINE BEECHAM CORPORATION;WELLS, MICKEY, LEE;DOUCET, DANY |
发明人 |
WELLS, MICKEY, LEE;DOUCET, DANY |